Top 20 of Mycoses

Article title # Publications/# Citations

The dorsoventral regulatory gene cassette spätzle/Toll/cactus controls the potent antifungal response in Drosophila adults.

1996: JAHoffmann; BLemaitre; LMichaut; ENicolas; JMReichhart;

513

Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group.

2008: European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group; National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group; JEBennett; JBille; TCalandra; BDe Pauw; DWDenning; WEDismukes; ... JPDonnelly; JEEdwards; RHerbrecht; WWHope; CAKauffman; CCKibbler; BJKullberg; OLortholary; JMaertens; KAMarr; GMaschmeyer; PMuñoz; FCOdds; PGPappas; TFPatterson; JRPerfect; ARestrepo; MRuhnke; BHSegal; JDSobel; TCSorrell; DAStevens; CViscoli; TJWalsh; JRWingard; TZaoutis;

298

NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007.

2008: National Healthcare Safety Network Team; Participating National Healthcare Safety Network Facilities; JREdwards; SKFridkin; AIHidron; TCHoran; JPatel; DAPollock; DMSievert;

281

Iron and infection.

1978: EDWeinberg;

263

Clinical, cellular, and molecular factors that contribute to antifungal drug resistance.

1998: RABowden; KAMarr; TCWhite;

245

Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990. National Nosocomial Infections Surveillance System.

1993: CBeck-Sagué; WRJarvis;

168

Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients.

2002: RACarter; LCorey; FCrippa; KAMarr; AWald;

155

The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee.

1995 Aug 23-30: DJBihari; HABruining; MHemmer; MHNicolas-Chanoin; RCSpencer; PMSuter; JLVincent; JWhite; MWolff;

148

Lessons from the genome sequence of Neurospora crassa: tracing the path from genomic blueprint to multicellular organism.

2004: LAAlex; RAramayo; DBell-Pedersen; KABorkovich; FBowring; DCatcheside; RDavis; JCDunlap; ... DJEbbole; MFreitag; JEGalagan; MGoodrich-Tanrikulu; HInoue; CIshii; ERKalkman; JJLoros; GMannhaupt; GAMarzluf; FENargang; RO'Rourke; JPaietta; IPaulsen; MPlamann; NPlesofsky; MPolymenis; RPratt; ARadford; NDRead; MSSachs; WSakai; USchulte; SSeiler; CSelitrennikoff; EUSelker; KSuzuki; GETurner; OYarden; JYeadon; AZelter;

143

The Drosophila systemic immune response: sensing and signalling during bacterial and fungal infections.

2007: DFerrandon; CHetru; JAHoffmann; JLImler;

136

The p47phox mouse knock-out model of chronic granulomatous disease.

1995: JIGallin; SMHolland; SHJackson;

134

TREM-1 amplifies inflammation and is a crucial mediator of septic shock.

2001: ABouchon; MColonna; FFacchetti; MAWeigand;

131

Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia.

2007: DAngulo-Gonzalez; OACornely; YTGoh; CHardalo; DHelfgott; JHolowiecki; JMaertens; JPerfect; ... MPetrini; DStockelberg; RSuresh; AJUllmann; TJWalsh; DJWinston;

129

Zygomycetes in human disease.

2000: DJBaker; JARibes; CLVanover-Sams;

126

Chytridiomycosis causes amphibian mortality associated with population declines in the rain forests of Australia and Central America.

1998: LBerger; AACunningham; PDaszak; CLGoggin; DEGreen; HBHines; ADHyatt; KRLips; ... GMarantelli; KRMcDonald; HParkes; MARagan; RSlocombe; RSpeare;

123

Role of oxidants in microbial pathophysiology.

1997: BEBritigan; RAMiller;

121

Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole.

1991: TRJohnson; JEKarp; WGMerz; MGRinaldi; RSaral; JRWingard;

120

Practice guidelines for the diagnosis and management of skin and soft-tissue infections.

2005: Infectious Diseases Society of America; ALBisno; HFChambers; PDellinger; EDEverett; EJGoldstein; SLGorbach; JVHirschmann; ... ELKaplan; JGMontoya; DLStevens; JCWade;

120

Real-time PCR in clinical microbiology: applications for routine laboratory testing.

2006: SPBuckwalter; FRCockerill; MJEspy; MFJones; JERosenblatt; LMSloan; TFSmith; JRUhl; ... EAVetter; NLWengenack; JDYao;

118

Comparison of In vitro activities of the new triazole SCH56592 and the echinocandins MK-0991 (L-743,872) and LY303366 against opportunistic filamentous and dimorphic fungi and yeasts.

1998: AEspinel-Ingroff;

117